RxDoctor Payments Data

James Coghill, MD

Hematology & Oncology · Chapel Hill, NCNPI 1801000880

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology & oncology clinicians in NC, where the typical reported total is $1,703.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$192,363in research payments, 2019–2025

Across 14 payments — averaging $13,740 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$123K
  • Sanofi US Services Inc.$69K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 358 hematology & oncology providers in North Carolina.

See all hematology & oncology providers in North Carolina →

Medicare billing

Part B allowed, 2024
$34,131
Medicare patients
56
Services billed
376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JakafiRuxolitinib Phosphate51$842,389
ValacyclovirValacyclovir Hcl37$2,791
Budesonide DrBudesonide11$561
Prednisone31$188
Pantoprazole Sodium16$96
Amlodipine Besylate13$77
Gabapentin11$48

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Chapel Hill

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →